Effectiveness of an intelligent endoscopic assistant device for detecting gastric neoplasms and its application conditions: a multi-center, randomized, controlled trial

IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES The Lancet Regional Health: Western Pacific Pub Date : 2025-02-01 DOI:10.1016/j.lanwpc.2024.101308
Zehua Dong , Lianlian Wu , Hongliu Du , Xiao Tao , Junxiao Wang , Xiaoquan Zeng , Yijie Zhu , Shuzhe Tan , Jiamin Wang , Mei Deng , Ting Yang , Lilei Yu , Honggang Yu
{"title":"Effectiveness of an intelligent endoscopic assistant device for detecting gastric neoplasms and its application conditions: a multi-center, randomized, controlled trial","authors":"Zehua Dong ,&nbsp;Lianlian Wu ,&nbsp;Hongliu Du ,&nbsp;Xiao Tao ,&nbsp;Junxiao Wang ,&nbsp;Xiaoquan Zeng ,&nbsp;Yijie Zhu ,&nbsp;Shuzhe Tan ,&nbsp;Jiamin Wang ,&nbsp;Mei Deng ,&nbsp;Ting Yang ,&nbsp;Lilei Yu ,&nbsp;Honggang Yu","doi":"10.1016/j.lanwpc.2024.101308","DOIUrl":null,"url":null,"abstract":"<div><div>Evidence about the effect of AI systems on upper endoscopy in multi-center, randomized controlled trials is lacking. We aimed to explore whether AI can enhance gastric neoplasm detection and how AI can be applied better in real clinics.</div><div>Patients from 24 hospitals were allocated to receive AI-assisted esophagogastroduodenoscopy (EGD) or non-assisted EGD from December 21, 2021, to November 11, 2023 (pre-registered, ChiCTR2100054449). Primary outcome was detection rate of gastric neoplasms. Secondary outcomes included detection rate of early gastric cancer and precancerous conditions, biopsy rate, number of blind spots, and procedure/inspection time. We did modified intention-to-treat (m-ITT), per-protocol (PP) analysis, and an exploratory subgroup analysis.</div><div>A total of 30,540 patients were enrolled. In m-ITT cohort, the detection rate of gastric neoplasms under assistance was higher (RR 1·13, 1·00-1·28; 4·00 vs. 3·52%, p=0·04) with consistent results in the PP cohort. While after a pre-specified pathology review, numerically more gastric neoplasms were detected (RR 1·12, 0·92-1·38; 1·41 vs. 1·26%, p=0·28) with no statistical significance, and the result in PP analysis was consistent. Moreover, the system reduced the number of blind spots from 2·52 to 1·07 and increased the procedure/inspection time significantly. In exploratory subgroup analysis, potential benefits of AI in less experienced endoscopists and fatigue periods were detected. In the experimental group, the AI diagnosed the gastric adenocarcinoma with a sensitivity of 100%.</div><div>In conclusion, the ENDOANGEL-GC reliably contributed to the homogenization and standardization of endoscopic quality. The detection of gastric neoplasms was numerically improved without statistical significance. Our exploratory analysis seeking the optimal application condition of ENDOANGEL-GC found that AI might play a promising role among less experienced endoscopists and in labor-intensive areas, provides preliminary evidence for future researches.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"55 ","pages":"Article 101308"},"PeriodicalIF":7.6000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Regional Health: Western Pacific","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S266660652400302X","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Evidence about the effect of AI systems on upper endoscopy in multi-center, randomized controlled trials is lacking. We aimed to explore whether AI can enhance gastric neoplasm detection and how AI can be applied better in real clinics.
Patients from 24 hospitals were allocated to receive AI-assisted esophagogastroduodenoscopy (EGD) or non-assisted EGD from December 21, 2021, to November 11, 2023 (pre-registered, ChiCTR2100054449). Primary outcome was detection rate of gastric neoplasms. Secondary outcomes included detection rate of early gastric cancer and precancerous conditions, biopsy rate, number of blind spots, and procedure/inspection time. We did modified intention-to-treat (m-ITT), per-protocol (PP) analysis, and an exploratory subgroup analysis.
A total of 30,540 patients were enrolled. In m-ITT cohort, the detection rate of gastric neoplasms under assistance was higher (RR 1·13, 1·00-1·28; 4·00 vs. 3·52%, p=0·04) with consistent results in the PP cohort. While after a pre-specified pathology review, numerically more gastric neoplasms were detected (RR 1·12, 0·92-1·38; 1·41 vs. 1·26%, p=0·28) with no statistical significance, and the result in PP analysis was consistent. Moreover, the system reduced the number of blind spots from 2·52 to 1·07 and increased the procedure/inspection time significantly. In exploratory subgroup analysis, potential benefits of AI in less experienced endoscopists and fatigue periods were detected. In the experimental group, the AI diagnosed the gastric adenocarcinoma with a sensitivity of 100%.
In conclusion, the ENDOANGEL-GC reliably contributed to the homogenization and standardization of endoscopic quality. The detection of gastric neoplasms was numerically improved without statistical significance. Our exploratory analysis seeking the optimal application condition of ENDOANGEL-GC found that AI might play a promising role among less experienced endoscopists and in labor-intensive areas, provides preliminary evidence for future researches.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
The Lancet Regional Health: Western Pacific
The Lancet Regional Health: Western Pacific Medicine-Pediatrics, Perinatology and Child Health
CiteScore
8.80
自引率
2.80%
发文量
305
审稿时长
11 weeks
期刊介绍: The Lancet Regional Health – Western Pacific, a gold open access journal, is an integral part of The Lancet's global initiative advocating for healthcare quality and access worldwide. It aims to advance clinical practice and health policy in the Western Pacific region, contributing to enhanced health outcomes. The journal publishes high-quality original research shedding light on clinical practice and health policy in the region. It also includes reviews, commentaries, and opinion pieces covering diverse regional health topics, such as infectious diseases, non-communicable diseases, child and adolescent health, maternal and reproductive health, aging health, mental health, the health workforce and systems, and health policy.
期刊最新文献
Cost-effectiveness analysis of switching from a bivalent to a nonavalent HPV vaccination programme in China: a modelling study Strategies for the prevention of ischemic stroke in atrial fibrillation in East Asia: clinical features, changes and challenges Prevalence of chronic kidney disease among Chinese adults with diabetes: a nationwide population-based cross-sectional study A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients Middle-age cerebral small vessel disease and cognitive function in later life: a population-based prospective cohort study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1